Cunningham GR - Search Results

1

Managing the risks of prostate disease during testosterone replacement therapy in older men: recommendations for a standardized monitoring plan.

Bhasin S, Singh AB, Mac RP, Carter B, Lee MI, Cunningham GR. Bhasin S, et al. Among authors: cunningham gr. J Androl. 2003 May-Jun;24(3):299-311. doi: 10.1002/j.1939-4640.2003.tb02676.x. J Androl. 2003. PMID: 12721204 Review. No abstract available.

2

Effects of finasteride on the rat ventral prostate.

Shao TC, Kong A, Marafelia P, Cunningham GR. Shao TC, et al. Among authors: cunningham gr. J Androl. 1993 Mar-Apr;14(2):79-86. J Androl. 1993. PMID: 8390428

3

Transdermal testosterone gel improves sexual function, mood, muscle strength, and body composition parameters in hypogonadal men.

Wang C, Swerdloff RS, Iranmanesh A, Dobs A, Snyder PJ, Cunningham G, Matsumoto AM, Weber T, Berman N; Testosterone Gel Study Group. Wang C, et al. J Clin Endocrinol Metab. 2000 Aug;85(8):2839-53. doi: 10.1210/jcem.85.8.6747. J Clin Endocrinol Metab. 2000. PMID: 10946892 Clinical Trial.

4

Long-term pharmacokinetics of transdermal testosterone gel in hypogonadal men.

Swerdloff RS, Wang C, Cunningham G, Dobs A, Iranmanesh A, Matsumoto AM, Snyder PJ, Weber T, Longstreth J, Berman N. Swerdloff RS, et al. J Clin Endocrinol Metab. 2000 Dec;85(12):4500-10. doi: 10.1210/jcem.85.12.7045. J Clin Endocrinol Metab. 2000. PMID: 11134099 Clinical Trial.

5

Long-term testosterone gel (AndroGel) treatment maintains beneficial effects on sexual function and mood, lean and fat mass, and bone mineral density in hypogonadal men.

Wang C, Cunningham G, Dobs A, Iranmanesh A, Matsumoto AM, Snyder PJ, Weber T, Berman N, Hull L, Swerdloff RS. Wang C, et al. J Clin Endocrinol Metab. 2004 May;89(5):2085-98. doi: 10.1210/jc.2003-032006. J Clin Endocrinol Metab. 2004. PMID: 15126525 Clinical Trial.

6

New testosterone buccal system (Striant) delivers physiological testosterone levels: pharmacokinetics study in hypogonadal men.

Wang C, Swerdloff R, Kipnes M, Matsumoto AM, Dobs AS, Cunningham G, Katznelson L, Weber TJ, Friedman TC, Snyder P, Levine HL. Wang C, et al. J Clin Endocrinol Metab. 2004 Aug;89(8):3821-9. doi: 10.1210/jc.2003-031866. J Clin Endocrinol Metab. 2004. PMID: 15292312 Clinical Trial.

7

Testosterone replacement therapy for late-onset hypogonadism.

Cunningham GR. Cunningham GR. Nat Clin Pract Urol. 2006 May;3(5):260-7. doi: 10.1038/ncpuro0479. Nat Clin Pract Urol. 2006. PMID: 16691239 Review.

8

Testosterone replacement in men.

Beg S, Al-Khoury L, Cunningham GR. Beg S, et al. Among authors: cunningham gr. Curr Opin Endocrinol Diabetes Obes. 2008 Aug;15(4):364-70. doi: 10.1097/MED.0b013e328305081a. Curr Opin Endocrinol Diabetes Obes. 2008. PMID: 18594278 Review.

9

Low testosterone associated with obesity and the metabolic syndrome contributes to sexual dysfunction and cardiovascular disease risk in men with type 2 diabetes.

Wang C, Jackson G, Jones TH, Matsumoto AM, Nehra A, Perelman MA, Swerdloff RS, Traish A, Zitzmann M, Cunningham G. Wang C, et al. Diabetes Care. 2011 Jul;34(7):1669-75. doi: 10.2337/dc10-2339. Diabetes Care. 2011. PMID: 21709300 Free PMC article. Review. No abstract available.

10

Andropause or male menopause? Rationale for testosterone replacement therapy in older men with low testosterone levels.

Cunningham GR. Cunningham GR. Endocr Pract. 2013 Sep-Oct;19(5):847-52. doi: 10.4158/EP13217.RA. Endocr Pract. 2013. PMID: 24014001 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results